Temperature Screening Ineffective, CDC Study Shows
A new CDC study confirms what global public health officials have said: temperature screening is ineffective. This 80-second video explains it:
Inside, IPVM analyzes the study and explains what it found.
Executive *******
*** *** ******* *-****** ** *********** screening, ***** ******** ***** *********, ** U.S. ******** **** ******** ****** ****** and **** ***** * ****** ******** case. **** ***** **** ****** *** rare (* ** ******,*** ****** ********), that ~**% ** ****** **** ****** did *** **** ***********, *** **** self-reporting ** **** ***** ** ********* at ******* ****** ** *********.
**** ********* ****"*******-***** ********* ******** *** ***********", ******* coronavirus ******** *** ************, ******, *** the ********** ****** ** ****.
750,000+ ****** ********
*** *** ***** ****** ** *-****** of *** *********** ******* ********* ******* in *.*. ********. **** ***,*** ****-**** passengers **** ******** *** * ****-********* symptom **** *** ***** ********* **** a ******** ***-******* *********** ***, ******** that *** ** ******** ******** **** fever, **** **** *** ********* ********* by ******* ******** *** *** *********** testing.
99.993% ** *****
**.***% ** ****** ******** *** *** have * ***** (*.*., ***,*** ** 776,044) ** *** *** ***** ************ how **** ** ** *** ****** to **** * ***** ** * public ***** **** ** *******:
Screening ***********
*** *** ********* **** ******* ********* is *********** ******* ** ****** **** 9 ***** *****, ******* ***** ******, and *** *********. *** ********* **** ********** * **** *** 85,000 ******** ****** *** **** *% of ****** *** ********* ****** ****** positive *** *****-**. ** ********, *********** screening **** ******** ** ****** **** fevers, .***% ** ****** ******** *** ~90% ** ***** **** ***** *** to **** *****-**.
*** *** ********* **** ******* ********* is ********* *** **** *** **** well, *** ***** *** ********* *******.
Coronavirus ******** ****** *** ************
*** *** **** ******* ********* **** not **** ******* ****** *** **** different ** ** ********, *** *** period ****** ******** ****** ** ****. They *** *** ****** ** ****** without ******** **** ***** ***** ********* ineffective ** ******** *****. ** ********, the ************* ** ******** ***** **'* hard ** ************* ******* *********** *** other ******** ***** ** ***** ********. Also, ********** *** ****** *** ** report ******** ** ** **** ****. These *** **** ******* ********* *** coronavirus ***********, **** ************* ***** *******.
Echoes *****
**** ************* **** ****** ****** ****** ************* **. ***** ** *** ** Health ******** **** **** ***** *** ineffectiveness ** ***** *********.
Counters ***** ****** *********
**** ***** **** ******* ** ***** camera ************* *** ********** **** ********* that ** **** *** *** ********* for ******, **** ***** ** **** liable *** *** ********* ******** ****** measures. **** ** *** ******* **** not ****** (**** *** ** ****'* testing), **** ************* ***** ***** **** the ** ********** ***** **** *********** screening ** ***********.
** *** **** ** *** ******** time, *** ******* ** *** ********** of ************ ******** ******, ******** ********* it *** *****.
**'* ** ********* ** ****** ***** into ***** ****-******** ** ******** **** in *****. ******* ************ ****'* **** found ** ** ******. ** ****'* know *** ** *******, ** ** did ********** ** ****************.
* ***** ** ******* ***** $**** thanks ** ***** **** ******** ***** their *************.
*** ***** *** ******* **** ******* the ************* ** ***** ***** ******* to ****** ****** *** ******* ********* versus ******** ********* ****** (****, *** every **** ******)?
*** ************* ** ***** ***** ******* to ****** ****** *** ******* *********
***, **** *****. **** ******** ******** and **.***% *** *** **** * fever. **** ***** ********* ***** **** person ****** *** *******?
*********** ********* **** ******** ** ****** with ******, .***% ** ****** ******** and ~**% ** ***** **** ***** not ** **** *****-**.
** *** ******** ********* ******** (****'* what * *** ******* ** ** saying ***** *****), **** ********** ***** have **** ***** ** **** *****-**? Does **** ***** ******* ****?
* ***** *'* ******* *** ************ **** **********.
** *** ******** ********* ******** (****'* what * *** ******* ** ** saying ***** *****), **** ********** ***** have **** ***** ** **** *****-**?
** *** *** ****** ***** *** ground *****, *** ***** **** *** include ****. *******, ***** ****** **** selected ******* **** **** ****** **** countries **** **** ********** ** ***********, like **** *** *** ****** *******, so ** ** ****** **** **** people **** *********** **** *** ******.
*** ***** **** ******** **** ******** are ********** **** ****** **** ********* symptom ********* ***** *** ****** **** cases, ******** **** **** ******* **** cases **** *** ******** ******* *********:
***** ******** *** ********** **** ************ models ********* *** ************* ** ******* screening *** *****-**, ***** ******* **** most ******** ********* ***** ** ********** by *******-***** ********* ** ******** (*,*).
**** *********** ********** ********** ** **** regards ** *********. *** **** ***** is **** *** *** *********. *** CDC ***** ********* **** ******** ********** are *********** ********* ** ** **** as * ********** ********.
*** *** ***** ********* **** ******** guidelines *** *********** ********* ** ** used ** * ********** ********.
**** ** **** ****** ** ****? I **** ********* ** *** ******** ****:
********* ********* ** ** ******** ******** that ********* *** ***.
**** *** **** ******* ** *********. If **** **** ****** ***** (********* in *** ********) ***** **** ****** their ****** ** ******** ********** *********** screening, ** *** **** **** **** to ****** *** *** *****.
***** **** *** **** * **** updated **** ** *** *, ** change ** *** ********* ******** * can ***.
**** ** ** *** ****** **********. **** ***** **** ****** ********* self-check ** **** ** ** ******** strategy *** **** ********** *** **** guidelines *** **** ***** ********* ** an ********, *** ** *** ******* it ** * ******** *** **********.
****, **** ***** ** *** **** with *** **** *** ****** **. Which *** ******** ** ***-********* ** a **** ********** *** *** ******?
*** ******** ** ********* ***** ** put **** ** *** **** ****, with *** **** **** ***-********* ** better ******* ** ******* *********** ** exposure.
***** *** ******** ** ***-********* ** a **** ********** *** *** ******?
"****** ** ** ********* ********* ***..."
***** ***** ****. *************, **'* * dropdown, *** ****, ** *** **** to ****** *** **.
*** ******** ** ********* ***** ** put **** ** *** **** ****
*'* *** **** **** *** ****** is *** ********** ***-*********, ******, **** accurate *****, ** ********* ****, *** the ******** **** ***** **** ** is *********.
****** ****, ***** * ***** **** give ********** ** ****-*********, * ***'* see **** **** *** ****** ****** screening ** *** * **********. **'** probably **** ************ *** ********** ******** differently.
* ** ***** *** **** **** they ********** ***********-********* *** ** *** ******* ***** methods. ***, **** ** *** ************ say *** ** *** ***** *******, they ****** ** *** ******* ****.
*****Content ** ********* ********* the first line states:
** *** ****** ** ******** ****** employees *** ******** ****** **** ******* on ****-*********, ******** ***** ******** ** include ** **** **********
******** ********* ***** ** ******* ******, the ******** ********** ***** ********** ** self-screening ******.
*****, * ***** **** ****'* ******* it ********** ** *** ***. **** do ******* ** ***** *** **** talking ***** ****** ******** ** ****** screening ** ****?
"*** *** ***** ********* **** ******** guidelines *** *********** ********* ** ** used ** * ********** ********."
** *** **** * ****** *** this ********* ***** **** ******** ****?
*** ******** *** *** ******* *********(*** 2) *** ***** ***** ***********/******* ********* as ** ******** ********.
***,***** *********** ********* ************ ***** ****-****** ** **** ** an ******** ********.
**** **** * ****** ******* **** in **** ******* ** *** *** and ** **** **** ****** ** how ** *********** ****** ** **********. Sound **** **-**** ********* ** ** option ***. ** **** ******* ** choose ****!
**** ******* ****-****** ****** ****** ** as ** ****** *** **** **** safety ****** ** *** ** ** in-person *********. *** *********** * *** is **** ********* ****-*********, *** ** people ****** ** ******, **** **** it ** ** **** ******.
**** ***** **** *** ***** ** a ***** ** **** *** ******* and ***** ******** ** * *****. The ***** **** ******* ** ******** the *********** ** ***** **** ************* travelers **** ********* **** *** ***** to ********** *** *****. **** *** thresholds *** ******* **** *** **********:
*** ********* *** ******* *********** ********* for ****** ****** ********** *** ******** which ***** ***** ***** ** **** for ******* ********** ****** ****** *** evaluation ******, ********** ********* ** ***’* definition *** “****** ***** *************”§§*** *********** ************** (*.*., ******* ********). Until ***** **, ********* **** ***** Province **** *********** *** ** **** upon ******* ***** ******* ** ***** authority.
*** ******* ** *** ***** **** highlights **** *** *********, *** **** fever, ** *********** *** ********* ** international ********* (***** ** * ****** misleading). *** ****** ** ******* ***** detection ******* ** ***, *** **** might ** * ****** ************* ** dismiss *** ***** ** ********* *** applications ******* ** *** ********** ** this *****. *** *** * **** the ***'* ****** ** **** **** study ** ********* ******* ** ************* travelers ** * ******* ** ******* from ********* **** **** *** ********** throughout *** *****.
**** ***** **** *** ***** ** a ***** ** **** *** ******* and ***** ******** ** * *****.
*** ***** ******** ***,*** ************ ** by *** *** ******* ***** ** have **** ** *********** ********. **** would ** ** *********** ***** ***** in **** *******, *** ***?
**** *** ******* *** ***** ******** as * *****
** *** *** ****** ** ***, we *** ****** **** ***** ***** it ***********.
**** *** ********** *** ******* **** not **********:
** **** *** **** **** *** definition ** ***** **** ******* **** if ********** *** ***** ******** ***:
****, ******* ********* *** *********, ***** included *********** *** ***** ** *******, a *********** ***** ***** * ********** infrared ***********(fever ******* ** *********** ≥***.*°* [**°*]),
***** ** * ****** **********
** ******* ** ***** ********* ******* that ** **** ******** ** *** audience. ** *************, *** *******, **** found ** ** ********* ** ***** have ********* ****.
**** ***** ** ** *********** ***** study ** **** *******, *** ***?
*** ****** **** ***'* *** *** issue ****, ** ** *** ***** (restricted ** ********). * ***** * better ***** ***** ** *,***,*** ****** temperature ********** ***** **** * ****** metric.
** *** *** ****** ** ***, we *** ****** **** ***** ***** it ***********.
** **** *** **** **** *** definition ** ***** **** ******* **** if ********** *** ***** ******** ***:
**** *****, *** **** ** *** study ** ****** ******** * ***** and **** ** ** ***** **** registered * ***** ******** * ****. Of ***** ** ******, * ****** positive *** *****-**. **, **% ** those **** **** ******** ****** **** back ********. **** **% ** ***** that *** * *****, *** ******. While *** ********** ** * ***** did *** ******, ********** *** ******** to * ***** ***. ***** **** deeper **** ** ** *** *** that *** *** ******** **** **** tested. ** *** ** ** *** positive ***** ** ***** ******, **%, then *** ** *** *** **** met *** ********...** ***** ** ******** and *** *** * ********.
* ***** * ****** ***** ***** be *,***,*** ****** *********** ********** ***** give * ****** ******.
* ***** **** ***** ** * better *****, *** ** **** *** seen ******** *******.
**** *****, *** **** ** *** study ** ****** ******** * ***** and **** ** ** ***** **** registered * ***** ******** * ****.
*** **** ***** ******* ** ***** was * ****** ***********, *** * coronavirus ****. **, *** ******** *** have ********** ***** *********** **** * more ******** ****** *** ***** ** to ** ******, ***** **** *** for ******* ******, ** ***** *** not **** **** ******* ********. ******** people **** ******** *** ****** *** be ****, *** *** *** ******** the ******** *** **** ** * medical ******** ***** ** ***** ********* of *** ********' ********.
**********, **** ** *** ****** *** amount ****** ** ***** *********, *** number ***** ***** ***** ** **: 15/776,044 ************ ** *.****%. *** ******* screening ******* **/***,*** ** *.****%. ** you ***** ***** ******* ***** **** a ********* **********?
**** *** ***** ****** **** **** travelers **** *** **** ** ***** facility ** ***** *** *****-**. ** they ***** **** *** ******** ** the ****** *** *******.
*** ******** ** **** ****** *** subject ** ** ***** ***** ***********. First, *** *** *********** ********* **** referred *** ****** ****** ********** ******* many *****-** ******** *** *********** *** available **** (*** ********* *** **** not ********) *** ************ ** ********* the ********** *** ***** **** *** some ********.Second, **** ********* ******** *** ****** ****** ********** **** *** **** ** * ***** ****** **** ******** ** ****** *** ****-***-*. Both could have been sources of selection bias toward underestimation of the number of cases in screened travelers.
* **** **** ** *** ****** states ***** ******** *** *******, *** can't ****** **** ********* ** *** effective. ********* ***, *** *********** **. Out ** *** *** ****** ********, 48 ****** *** * *****. **** though *** *** **** ******, * (10%) **** ********. * * ** 10 ****** ** * ****** ***** having * ***** *** **** ****** COVID ** * ****** **** ***. This ** ***********, *** ***** ****** who **** *** ******* ** **** on ***** ****** ** *** ****** of ***** ********** ** ***...* **** I **** ****** **** * ***'* feel ****.
*******/******** ** * ***** ****** ******** came ***** **-**** ****** ***********. **** could **** *** ** ***************, *** the **********/******** ****** **** ******** *** random
The ***** **** included referral of ill travelers and those disclosing an exposure for additional public health assessment ** ** **-**** ******* *******; if *********, travelers were sent to a local health care facility for medical evaluation.
*** **** *****, **** * ******* the *** ** ******, ** *** that *** ****** ****** ******** ** they *** *******, *** **** **** are ** *********** *** ** ********* for ***********.
* * ** ** ****** ** a ****** ***** ****** * ***** and **** ****** *****
** *** **** ***** ** ** diagnosing ***********. * ** ** ** way ********** ****** **** ****** ****** come **** ******* **** ******. ****** are * **** ******* *** ** contagious **** ********* *** **** **** should **** **** ** ***** *********** spreading ******** ** **.
* (** **)/***,*** ** *** ********* fever ********* ** ** ******* ****** with *********** **** * ********** ******** to ** ****-****. **** ** *** number **** ** *** ********* ***** fever ********* ***********.
*** ** *** *** ****** ********, 48 ****** *** * *****. **** though *** *** **** ******, * (10%) **** ********. * * ** 10 ****** ** * ****** ***** having * ***** *** **** ****** COVID ** * ****** **** ***.
*** **** ***** ** *** * out ** ***** **,***+ ****** * fever. **** ** *** **** '******** who ******** * ***** *** ***********', that's ***** *.***%. *** ** **** there's **** ** **** ** **** a ***** *** *** **** ***********.
*** ***** ****** *** **** *** decided ** **** ** ***** ****** so *** ****** ** ***** ********** is ***...* **** * **** ****** when * ***'* **** ****.
***** ****, *** *** *** **** reason, ****** *** **** ****** *** unlikely ** ** ** ******* ******, the ******* *****, ***.
******* * ******** ***** ****** **** fevers ***** **** ****** **** ** go *** *** ** **** **, what's *** ********** ****? * ** 10,000? * ** *,***?
**'* ********* *** ****** ** ********** how **** **** **. ******* ****, also ***** ** **** ****** *** easy ** ** ********* ** *** a ****** *** **** ****** ******* it *****, ***** **** ****** *** so ****.
***** ****, *** *** *** **** reason, ****** *** **** ****** *** unlikely ** ** ** ******* ******, the ******* *****, ***.
***, * ****** **** ** ***** out, **** *** ****** *****.
*** **** * ******** ****** **** arrested ******** * ****** *** ********* are ********...*********** **** **** ****** ******** then **** ******* **** * ******** of ***** *********** *** "** *** Fly" ****, *** ** ******.
**** ********** *** **** ** *** the ****** ********** ** ******, ******* they ****'* ******* **** **** *****. You've **** ** *** **** ****, if *** ****, ******** ** ******** are ******* *** ****** *** ** on *** ******, *** ****'* **** they ****** ** ** **** *****. They ******* **** ******** ****** **** the **** *******, ***** ********** **** up *******. **** ** *********** ************** ** *** ***'* ****, ***** used ******* ******* *********. *** ******** IR ******** ****** ***** **** ***** up ** * "**** ********" ** compare ***** ************ *******.
*** ***** *** ********** *** ******* *****.
**** ************ ********* ** **** ***** are ****** *** ***** ** *** current *****.
***** **** *** ********* ** ***** much ****** **** ****, ** ************* the ******* *** *** ** * fair **********.
**** **** *** **** **** *** those *** ***** *** **** ****** by *** ******* ****** ***** *** salesmen *** *** *** ***** ***** back? /*
***** ***, ******* *******, *** ******* screening - ******* ****-***.
** ** ******** ** **** **** exactly **** **** ** ********* **** infrared **** ***?
*** ******* **** ******* **** **** did ******** ************ **** * ** thermometer. *** **** ** *** ******** or *** ** *** ******* ************?
**** ***** * **** ********* ** the ******** ****** ****** * **** res ******** ** *** ******* ***** give ******* *** ******* ** ******, but ** ***** ** *********** ** see.
**** ***'* ******* ****** "********** ******** ***********" ***** ******** ***** "using * **** ********* ** *** forehead" ** ******* ** ****** ** manually ****** *** ***** *******.
** *****'* ***** * ********** ******** **** ** ******: ** ******** handheld ** ***** ** ** ******** high *** ******** **** ******* **** as ******* **** *** ***** ******* and ******* **** ******* ** *** device ******.
** ******** *** ***** ****** ******* was **** ** **** ***** ***** important ** **, ** *** **** shown ** **** **** ******* **** summer *** *** ********* ******* *** equal *** **** **.
**** ** **** *** ** **** reached ***. *******, ******** ********** ************ often *** **** * ****** ***** from ***** **, ******* ** **** from *** ****, ** ***** *** be **** *********** ** ******** *********** than *** ****** *** ******* ** have ******. *** ** ** ***** good ** ****.
***** * **** * ********** **** IPVM **** *** *** ******* ** this ******* **** ** ***** ** that *** ** ** ** *** industry *** **** ** **** **** more ****** ********** ?
********, ******** ** ****** (** *******)*** *** **** ** *** ***** is ** **** ** **** ** share *** ***. **** **** ****** ****** ********* **** ** ***** **** ****** more ******.
*** ****** ** **** ******** *** discussion ***** *** *******.
**** ** **** *** * **** John *. ***** *** ***** ********* for *** ***** *****? ****** *** excessive *** ** *** **** "******". Indeed, **** ****** ********* ** *********** statement **** *** ****, "******".
; )
******, ***** ***** ****** ******, ***** **** ****** ** ** a ****** *********** ******* ********* * sentence **** "******" *** **** ********'* authorship. ** ****** ** *****, *******, that ** ** *** ***% *******. Other ***** ******* *** **** ************ from **** ** ****,******************************** ** *** ****. ******* **** is * **** ** ***** **** John (******** ** ** ***'* ********) or ******* **** *** ************** ******* up *** ****** ********, * ***'* know.
****** **! *'* ****** *********** ** my ******* ** ********** ******** *********** authors ** **** *****. ********** *** that ******* ******* ***** **** ******* to ******* ***********.
***********, **** ** ****** ** ********,**** others.... ***** **** ***** **** ** you *** **** *********.
* *** *** ********* *** ***'* like ** ** **** **** ** smash * ***** ****.
*** ** *? ;)
** ****** **** **** ***** * fevers ** **** **** **********, ******* the ******** ** ******** *** ****** every ******* ** *** ****** ****** their ******* ** ********, *** ******* are ********* *******. ** * ******* population * **** ****** **** *****'* push ******* ** *** ******* ******** have *** * ***** ******** **** of ** ***** * *** ******* (meaning, ***** ******* ** **** **** at ***** * *** ********* ** false ********* ********* * ****** ****, its * ***** *** **** **** there *****'*). **** *** ***-******* ********** (forehead) ** ******** ** **** ******* averaging ** *** ****** **** ***********, which *'** ********** (*** ****** **** IPVM) ** *** ******* **************.***. ** ****'* **** *** ******, they ***** **** ****** ******** **** fevers. ** *** ** ***** *** we ***** ** *** ** ******** only *** ** ***** ********* *** doesn't **** ** ***** ******* ** order ** *** ****** ****** ********, but *** ****** ** *** ****** has ******* **** ****. * **** forward ** ******* ***** *** ***** action ******** ******* **** ** ***** sellers.
***** ******** ********* ***** * *** high-level *********** *** ** *******, ******** , ***-******* ***********. ** ******* ********. I ****** *** *** ***** ********** the *************? [* *********** ***** ***** * ********** infrared *********** (***** ******* ** *********** ≥100.4°F [**°*]),]
****** **** **** ** ** ********** that ****** **** **** **********. **** that **** **** **** ** **** in ******* *** *** *****, ** is ** ** ********** ** *******/**************. Maybe **** *** ************ **** *** or ***** ************.
* ****** *** *** ***** ********** the *************? [* *********** ***** ***** * ********** infrared *********** (***** ******* ** *********** ≥100.4°F [**°*]),]
****** *********** *********,***** ********** *********** ** ** ******:
******** *********** *********** ******** ** ***** the ********* ** ****-****** ***** ** coming ****** *** *** ** ******* to ***** *** ********* ** *** of *** ********* *** *******:
...
***** ***** ** ** ****** **** 100.4***
***, ****-********* ****** *.* ***** ** many ****** ** ******** *********.
*** ** ****** ********* ***** ******* some ******, *** ******* **? ********** if *** *** ** ********** ********* that ** **** *** *****:
*** ********* ** ****** ** *** worse, **** ******* *** ******* ******* and ********** ******** ****** ******** ******* that *** **** ***** ****** *** “going ** ** *** **** ********* time ** *** ****** ****** ******* of **** ******.” ******** **** *** U.S. ***** **** — ********* ** 272,000 — ***** ***** ***,*** ** February.
*******, ******* ******** ** **** ** home **** *** *********** *****.
****, ** ** ******, ****** ** ineffective. ** *** **** ** * false ***** ** ******** *** ********* can ** ***** *********, **** ** ***********, ******** ********, ***, *** ***** *** **** **** impact. **** **** ** *** **** any ********* ***** *********** ******** *** symptoms ** **** (***** *** *** use **** ******** ************), ****** ***** the ******** ** ***** ********* *** symptoms *** ******.
****, **** ****** ** *********** ** relation ** ****** ****** ***** ** not *** **** ** * ********* or ******** ***********. ********** ****'* *** as * **** *** ****, *** of *** ****** *** ********* ********* changes ** ***********, ******** ******** *** PPE *** ******* ***** ****, ********* would ** ** ***** ***** ** top ** ****.
*** ****** **** ***** ********** ****** be ******* ****** ** *** ***** sense ** ******** *** ******* *** user ****. *** **********, ** *** end ****, ** **** ** *** thermal ****** *** *** **** *** target *** * ***** **** *** is **
* ***** **** *** * ******* camera, * ** *** * ********* of ***** ******* ******* *** ********* at **** ****. * *** ********* to *******/******* ********** *** ** ******* those *** ** ***** ** ******** spread...not * ***** *** ********. ***** is *** ***** **** ***** *** is ******* ****** ** ** ** home. ***'* **** ***** ******** ****, but *'** ***** ********** ** ** home *********** ** ***** *** **'* accuracy.
*** *'** ***** ********** ** ** home *********** ** ***** *** **'* accuracy.
**** *** *** ************ *** ********** more ******** **** ******** ****, ***** makes ***** ******* **** *** ****** in **** ***** ** *** ************ as ******* ** ******* ****** ** feet ****. ***** *********** ** *********, if * ****** ** *** ********, calibration ****** **** ** *** **. And, *** *** **-**** ******* *** calibratable, ** ******* ************. *******, ******** devices *** ** ************* ***** ***** make **** ********** ** ****.
** *** *** *******,**** *** *********** ** ********* ******** ****** I *****. ***** ***** ** ************ on **** ******* *** ****, ******** supports **** *** *** ** ******** to ***** *******.
***** ******* *** *** *****, * more ******** ***** *** *** ***** would **** ****: ** ****** ****** practice, *** ***** *******-***** ********* ******** are ***********. *** **** ********* ******* is *** ******** ** *********** *******, nor ** ***** ******** ** *** report ********** ******** ** ***** ******* in ********* ******* *** ** *******, instead ** ********* ****** **** *** kind ** ******* ***** ********* ** arriving ********** **** *** ******** * good ****** ** **********.
* **** ***** ** ****** **** from *** ********* * *** *** feel **** *********** ********* ***** ** an ********* *** ** ****** ***** 19 *** **** ***** ********* ******* are ***** ** **** ** **** than **% ** *** ******** ******. This ***** **** **** ** ******* that, ********** ** *** ***** *********** made.
*************, **** ******* *** *** ***** does *** ******* ** *** *** context ** *** *********, ***** *** made ** ** *********** *** ****** health ******** ** * ******** ********, and ** * ********* *************, *** group ***** ******* *** ******* ** those ********* *************** *** *** **** specific *********.
****** ****** ******** **** ******** ** concerned ***** *** **** *** ** limited *********, ** *** **** **** by ************* *** ******* ********* *******, they ***** *** ****** *** ***** people ** ***** ***** **** *** contribute ** ******** ****** ** *** virus. ** *** **** ** **********, since **** ****** ******* ** ********* the ***** **********, ***** ** ** benefit ** *** ****** *** ********. As **** **** ***** *****, ***** is ** **** ** ****** ******* to * ******** ********** **** ***** of ********* ** **** ********** ** additional **** **** ***** *** ** to *** ********* ** *** ****** it ****** ** *****.
**** ***** *** *** ******* ******** in ************* *** ****** **** ****** from ******* ******** *** *** ***** Cracker ****** ** ***** ** ****. This ******** *** **** **** *** airlines **** ********** ***** *** ***-**********, international *** ****** ** ***** * bit **** ******** **** * ***** to * ***** ********, *** *** fact **** *** ****** *** ******* to * ******** **** ** ********* countries ****** **** *** ******** **********.
*** ***** *** ***** ***** ** themselves ***** **** **** ***** ******** showing ******** ***** ** **** ****** to *** ** *** ***** **** are ******** ** ******* ******. *** report ****** ****** *** *** ***********, one *** *** ***** *** ******** who *** ******* *** * ***** test ** **** *** * ********** provider, ** ********** ** ***'* **** if *** ** ***** ***** ** with * ***** ********* ***** **** the ****. ** **** ***'* **** how **** ****** *** **** *** flagged **** ************ ** *** ****, so ***** ** ** *** ** validate ****** ** ********, **** **** the ****/******** ********* *** ********* **** and **** ********** *** ***** ***** be ****** ***** ********* ** *** public ****** ******.
********** **** ***** ************** (***** **** being *** ** *** *** **** I *** ***** **) **** ***** justify *** *** ** **** **** of *********, ******* ** ******** *********** screening ** *** ** * ********* matter.
********** **** ***** ************** (***** **** being *** ** *** *** **** I *** ***** **) **** ***** justify
*** ** *** **** ********* ** this ***** **** *****? ******* ** fever *******. *** ******* ** **** CDC ***** ****** ******* ****** ******* **** **** spoken *** ******* ****.
*******, ** *** **** ** *** rigged ***** *******, **** ********* ** you **** ****?
****, **** ******* ***** ****** ******* are ***** ***** **** ** * tool ** **** ******* *****'* **** the ******* *****'* *****, *** * have **** ** ********* ** ******** back ** **** *****. * **** mentioned ** ****** ** *** **** as ********.
*** ** *** **** ********** * said (**'* * *** * ****) you'll ******* *'* *** ******* ***** fever ******* *** ********** *** **** of ******* ***** ********* ***** ** what *** *** ***** ** *****. In **** *** *** ***** ******* proves ** ********* *** ******** ** temperature ********** ******* ********** (*** ****'* even ******* ***** *******). *** ***** also **** *** ******* *** ****** up ******* *** ****** ** ************ carriers **** ******* ******* *** ********* making ** ****** ** ********** ********* effectiveness ******* ** ****/******** **********.
******* ** ******, *** ** *** health ******* ****** ** **** ****** report ************ ********* ***** ******* *** not ***** ***** ** ********* ***** is *** ******* * *** ******* about.
*******, *'* *** ******* ***** ******* but ** * *** ** ***** only ** ** ******** *******, *** I ***** **** ** ** * lot ** ******* ** ****** *** ones * ** ******* ****'* "******. I ********** *** ****** **** *** done ** ******* **** *** **** from *** *** ** ****.
** ***** *** **** *** ***** team **** ****** ** **** ******** that **** **** *********** ******, *** go **** *** ******** *****. * wasted **** ** ******** **** ****** sure ** ****'* **** ** ********* that ***** ***** *** ********* **** the **** ******* ** **'* ************* and **** **** ** **** **** that ** ***** **** ******* *** outer **** *********** *** *** *** core
*****, * ***** **** ** * prudent ********. * ********** ** *** think *** **** *** ***** *** price *** ** * ******** ***** to ****** *** ********* ***, *** and *** ********** **** * ***** be ***** ** **** **** *** install **.
*** ********* ** **** **** ********* don't **** ** ***** *** ***** needed *** * **** **********, *** or *** *** ** **** ** being ******** ** *** ******, *** at *** *** ** *** *** could *** ** ******** ********** ** a ******* ******* **** ******** ** used *** ****** **********.
*****...
*** ***** ****** **** **** ** fading ****...